Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine.
Saved in:
| Title: | Cancer genomic profiling identified dihydropyrimidine dehydrogenase deficiency in bladder cancer promotes sensitivity to gemcitabine. |
|---|---|
| Authors: | Tsukahara, Shigehiro1,2 (AUTHOR), Shiota, Masaki1 (AUTHOR) shiota.masaki.101@m.kyushu-u.ac.jp, Takamatsu, Dai1,3 (AUTHOR), Nagakawa, Shohei1 (AUTHOR), Matsumoto, Takashi1 (AUTHOR), Kiyokoba, Ryo2 (AUTHOR), Yagi, Mikako2 (AUTHOR), Setoyama, Daiki2 (AUTHOR), Noda, Nozomi2 (AUTHOR), Matsumoto, Shinya2 (AUTHOR), Hayashi, Tetsutaro4 (AUTHOR), Contreras-Sanz, Alberto5 (AUTHOR), Black, Peter C.5 (AUTHOR), Inokuchi, Junichi1 (AUTHOR), Kohashi, Kenichi3 (AUTHOR), Oda, Yoshinao3 (AUTHOR), Uchiumi, Takeshi2,6 (AUTHOR) uchiumi@cclm.med.kyushu-u.ac.jp, Eto, Masatoshi1 (AUTHOR), Kang, Dongchon2 (AUTHOR) |
| Source: | Scientific Reports. 5/20/2022, Vol. 12 Issue 1, p1-13. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
